Related Experiment Videos
Aetiology of fatal viral hepatitis in Melbourne. A retrospective study
Abstract:
In the period from January 1971 to June 1983, 46 of 5477 patients (0.84%) admitted to Fairfield Hospital, Melbourne, with acute viral hepatitis died of fulminant hepatic failure. The case-fatality rate for patients with hepatitis A was 0.14%; for patients with hepatitis B, 0.84%; and for patients with non-A non-B (NANB) hepatitis, 2.29%. The highest case-fatality rates were observed in patients with post-transfusion hepatitis B (18.8%), and in patients with NANB hepatitis aged less than 5 years (50%) and 40 years and over (10%).
Insights
Fulminant hepatic failure caused 0.84% of viral hepatitis deaths. Non-A non-B hepatitis had the highest fatality rate, especially in young children and older adults.
Area of Science:
- Hepatology
- Infectious Diseases
- Public Health
Background:
- Acute viral hepatitis is a significant cause of liver disease.
- Fulminant hepatic failure (FHF) is a rare but severe complication of viral hepatitis.
- Understanding risk factors and mortality rates is crucial for patient management.
Purpose of the Study:
- To determine the mortality rate of acute viral hepatitis.
- To analyze case-fatality rates for different hepatitis types (A, B, non-A non-B).
- To identify patient demographics with the highest risk of FHF.
Main Methods:
- Retrospective analysis of patient data from Fairfield Hospital, Melbourne (1971-1983).
- Inclusion criteria: patients admitted with acute viral hepatitis.
- Calculation of case-fatality rates based on hepatitis type and patient age.
Main Results:
- Overall FHF mortality was 0.84% (46/5477 patients).
- Case-fatality rates: Hepatitis A (0.14%), Hepatitis B (0.84%), Non-A Non-B (NANB) hepatitis (2.29%).
- Highest rates observed in post-transfusion Hepatitis B (18.8%), NANB hepatitis in <5 years (50%) and ≥40 years (10%).
Conclusions:
- NANB hepatitis poses a higher risk of FHF compared to Hepatitis A and B.
- Age is a critical factor influencing FHF mortality in NANB hepatitis patients.
- Prompt diagnosis and management are essential, particularly for high-risk groups.